Oseltamavir Phosphate (Page 8 of 8)

16 HOW SUPPLIED/STORAGE AND HANDLING

625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-876275-mg capsules (75 mg free base equivalent of the phosphate salt): Light yellow cap and grey body size ‘2’ hard gelatin capsules containing white to off white granules with “75mg” on cap and “M55” on body imprinted with blue ink. Available in

NDC: 70518-1727-00

PACKAGING: 1 in 1 CARTON, 10 in 1 BLISTER PACK

Storage

Store capsules at 20° to 25°C (68° to 77°F); excursions permitted within 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Preserve in well-closed containers. Store at controlled room temperature.

Repackaged and Distributed By:

Remedy Repack, Inc.

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Serious Skin/Hypersensitivity Reactions

Advise patients and/or caregivers of the risk of severe allergic reactions (including anaphylaxis) or serious skin reactions. Instruct patients and/or caregiver to stop oseltamivir phosphate capsules and seek immediate medical attention if an allergic-like reaction occurs or is suspected [ see Warnings and Precautions ( 5.1)] .

Neuropsychiatric Events

Advise patients and/or caregivers of the risk of neuropsychiatric events in oseltamivir phosphate capsules-treated patients with influenza and instruct patients to contact their physician if they experience signs of abnormal behavior while receiving oseltamivir phosphate capsules [see Warnings and Precautions ( 5.2)] .

Important Dosing Information

Instruct patients to begin treatment with oseltamivir phosphate capsules as soon as possible from the first appearance of flu symptoms, within 48 hours of onset of symptoms. Similarly, instruct patients to start taking oseltamivir phosphate capsules for prevention as soon as possible after exposure [ see Dosage and Administration ( 2)] . Instruct patients to take any missed doses as soon as they remember, except if it is near the next scheduled dose (within 2 hours), and then continue to take oseltamivir phosphate capsules at the usual times.

Influenza Vaccines

Instruct patients that oseltamivir phosphate capsules are not a substitute for receiving an annual flu vaccination. Patients should continue receiving an annual flu vaccination according to guidelines on immunization practices. Because of the potential for oseltamivir phosphate capsules to inhibit replication of live attenuated influenza vaccine (LAIV) and possibly reduce efficacy of LAIV, avoid administration of LAIV within 2 weeks or 48 hours after oseltamivir phosphate capsules administration, unless medically necessary [see Drug Interactions ( 7.1)].

Repackaged By / Distributed By: RemedyRepack Inc.

625 Kolter Drive, Indiana, PA 15701

(724) 465-8762

.

.

SPL PATIENT PACKAGE INSERT SECTION

Oseltamivir Phosphate (OH-sel-TAM-i-vir FOS-fate) Capsules, for oral use
What are oseltamivir phosphate capsules?
Oseltamivir phosphate capsules are a prescription medicine used to:
• treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than two days.
• prevent the flu in people who are 1 year of age and older.
It is not known if oseltamivir phosphate capsules are:
• effective in people who start treatment after 2 days of developing flu symptoms.
• effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.
• effective for the treatment or prevention of flu in people who have weakened immune systems (immunocompromised)
• safe and effective for the treatment of the flu in children less than 2 weeks of age.
• safe and effective in the prevention of the flu in children less than 1 year of age.
Oseltamivir phosphate capsules do not treat or prevent illness that is caused by infections other than the influenza virus.
Oseltamivir phosphate capsules do not prevent bacterial infections that may happen with the flu.
Oseltamivir phosphate capsules are not recommended for people with end-stage renal disease (ESRD) who are not receiving dialysis.
Oseltamivir phosphate capsules do not take the place of receiving a flu vaccination. Talk to your healthcare provider about when you should receive an annual flu vaccination.
Who should not take oseltamivir phosphate capsules?
Do not take oseltamivir phosphate capsules if you are allergic to oseltamivir phosphate or any of the ingredients in oseltamivir phosphate capsules.
See the end of this leaflet for a complete list of ingredients in oseltamivir phosphate capsules.
What should I tell my healthcare provider before taking oseltamivir phosphate capsules?
Before you take oseltamivir phosphate capsules, tell your healthcare provider if you:
• have problems swallowing oseltamivir phosphate capsules
• have kidney problems
• have any other medical conditions
• are pregnant or plan to become pregnant. Available information indicate that oseltamivir phosphate capsules does not increase the risk of birth defects.
• are breastfeeding or plan to breastfeed. Oseltamivir phosphate can pass into breast milk in small amounts.
Tell your healthcare provider about all the medicines you take, including prescription or over-the-counter medicines, vitamins, and herbal supplements .
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
How should I take oseltamivir phosphate capsules?
• Take oseltamivir phosphate capsules exactly as your healthcare provider tells you to.
• Take oseltamivir phosphate capsules with food or without food. There is less chance of stomach upset if you take oseltamivir phosphate capsules with food.
• If you miss a dose of oseltamivir phosphate capsules, take it as soon as you remember. If it is 2 hours or less before your next dose, do not take the missed dose. Take your next dose of oseltamivir phosphate capsules at your scheduled time. Do not take 2 doses at the same time.
• If oseltamivir phosphate for oral suspension is not available or you cannot swallow oseltamivir phosphate capsules, your healthcare provider or pharmacist may instruct you to open oseltamivir phosphate capsules and mix the capsules contents with sweetened liquids such as chocolate syrup (regular or sugar-free), corn syrup, caramel topping, or light brown sugar (dissolved in water).
If your healthcare provider or pharmacist has instructed you to open your oseltamivir phosphate capsules, read the detailed Instructions for Use at the end of this leaflet. Ask your pharmacist if you have any questions.
What are the possible side effects of oseltamivir phosphate capsules?
Oseltamivir phosphate capsules may cause serious side effects, including:
Serious skin and allergic reactions. Oseltamivir phosphate capsules can cause serious skin and allergic reactions. Stop taking oseltamivir phosphate capsules and get medical help right away if you get any of the following symptoms:

Change in behavior. People, especially children, who have the flu, can develop nervous system problems and abnormal behavior that can lead to death. During treatment with oseltamivir phosphate capsules, tell your healthcare provider right away if you or your child have confusion, speech problems, shaky movements, seizures, or start hearing voices or seeing things that are not really there (hallucinations).
The most common side effects of oseltamivir phosphate capsules when used for treatment of the flu include nausea, vomiting, and headache. The most common side effect of oseltamivir phosphate capsules when used for prevention of the flu include nausea, vomiting, headache, and pain.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all of the possible side effects of oseltamivir phosphate capsules. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store oseltamivir phosphate capsules?
• Store oseltamivir phosphate capsules at room temperature between 68°F to 77°F (20°C to 25°C).
• Safely throw away any unused oseltamivir phosphate capsules that are out of date or no longer needed.
Keep oseltamivir phosphate capsules and all medicines out of the reach of children.
General information about the safe and effective use of oseltamivir phosphate capsules.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use oseltamivir phosphate capsules for a condition for which it was not prescribed. Do not give oseltamivir phosphate capsules to other people, even if they have the same symptoms you have. It may harm them. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about oseltamivir phosphate capsules that is written for health professionals. For more information, call Macleods Pharma USA, Inc. at 1-888-943-3210 or 1-855-926-3384.
What are the ingredients in oseltamivir phosphate capsules?
Active ingredient: oseltamivir phosphate
Inactive ingredients: Oseltamivir phosphate capsules: croscarmellose sodium, isopropyl alcohol, povidone, pregelatinised starch, sodium stearyl fumarate and talc.
30mg capsule shell: gelatin, iron oxide red, iron oxide yellow, titanium dioxide.
45mg capsules shell: gelatin, iron oxide black, titanium dioxide.
75mg capsules shell: gelatin, iron oxide red, iron oxide yellow, titanium dioxide, iron oxide black
Each capsule is printed with blue ink, which includes shellac, propylene glycol and FD&C Blue No. 2 as the colorant.

This Patient Information has been approved by the U.S. Food and Drug Administration.
INSTRUCTIONS FOR USE
Oseltamivir Phosphate (OH-sel-TAM-i-vir FOS-fate) Capsules, for Oral Use
How do I mix the contents of oseltamivir phosphate capsules with sweetened liquids, if directed by my healthcare provider or pharmacist?
You will need:
• the prescribed dose of oseltamivir phosphate capsules
• a small bowl
• sweetened liquid, such as chocolate syrup (regular or sugar-free), corn syrup, caramel topping, or light brown sugar (dissolved in water)
Step 1. Open the contents of the prescribed dose of oseltamivir phosphate capsules into a small bowl.
Step 2. Add a small amount of the sweetened liquid to the capsule contents.
Step 3. Stir the mixture and give the entire dose of oseltamivir phosphate capsules.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.
Revised 12/2020 PM02470905

Repackaged and Distributed By:

Remedy Repack, Inc.

625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

o skin rash or hives o swelling of your face, eyes, lips, tongue, or throat
o your skin blisters and peels o trouble breathing
o blisters or sores in your mouth o chest pain or tightness o itching

DRUG: oseltamavir phosphate

GENERIC: oseltamavir phosphate

DOSAGE: CAPSULE

ADMINSTRATION: ORAL

NDC: 70518-1727-0

COLOR: yellow

SHAPE: CAPSULE

SCORE: No score

SIZE: 18 mm

IMPRINT: 75mg;M55

PACKAGING: 10 in 1 BLISTER PACK

OUTER PACKAGING: 1 in 1 CARTON

ACTIVE INGREDIENT(S):

  • OSELTAMIVIR PHOSPHATE 75mg in 1

INACTIVE INGREDIENT(S):

  • CROSCARMELLOSE SODIUM
  • POVIDONE
  • STARCH, CORN
  • SODIUM STEARYL FUMARATE
  • GELATIN
  • TITANIUM DIOXIDE
  • SHELLAC
  • PROPYLENE GLYCOL
  • FD&C BLUE NO. 2
  • FERROSOFERRIC OXIDE
  • FERRIC OXIDE RED
  • FERRIC OXIDE YELLOW
  • TALC
Remedy_Label
(click image for full-size original)
OSELTAMAVIR PHOSPHATE oseltamavir phosphate capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70518-1727(NDC:33342-258)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OSELTAMIVIR PHOSPHATE (OSELTAMIVIR ACID) OSELTAMIVIR ACID 75 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
POVIDONE
STARCH, CORN
SODIUM STEARYL FUMARATE
GELATIN
TITANIUM DIOXIDE
SHELLAC
PROPYLENE GLYCOL
FD&C BLUE NO. 2
FERROSOFERRIC OXIDE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
TALC
Product Characteristics
Color yellow (light yellow cap) , gray (grey body) Score no score
Shape CAPSULE Size 18mm
Flavor Imprint Code 75mg;M55
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70518-1727-0 1 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 10 CAPSULE in 1 BLISTER PACK This package is contained within the CARTON (70518-1727-0)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207211 12/12/2018
Labeler — REMEDYREPACK INC. (829572556)

Revised: 06/2021 REMEDYREPACK INC.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.